ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #7,693Hybrid

Molecular Imaging and Biology

Acronym:mibi
•
Abbreviation (ISO):MOL IMAGING BIOL
•
Identifier (ISSN):1536-1632(Print)/1860-2002(Online)
•
Publisher:Springer International Publishing
Clarivate IF (2026)
2.5– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Molecular Imaging and Biology

WoS Q2
12453.6120183.3420192.9220203.4920213.4820223.12023320242.520252.52026
Annual Impact Factor Metric
Current (2026):2.5
Scopus SJR & RankScopus Q2
0.74
#7,693

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
83

83 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate3.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
111articles/year
43.58% Gold OA•89.36% Original Research

Aims & Scope

Molecular Imaging and Biology (MIB) invites original contributions (research articles, review articles, commentaries, etc.) on the utilization of molecular imaging (i.e., nuclear imaging, optical imaging, autoradiography and pathology, MRI, MPI, ultrasound imaging, radiomics/genomics etc.) to investigate questions related to biology and health. The objective of MIB is to provide a forum to the discovery of molecular mechanisms of disease through the use of imaging techniques. We aim to investigate the biological nature of disease in patients and establish new molecular imaging diagnostic and therapy procedures. Some areas that are covered are: Preclinical and clinical imaging of macromolecular targets (e.g., genes, receptors, enzymes) involved in significant biological processes. The design, characterization, and study of new molecular imaging probes and contrast agents for the functional interrogation of macromolecular targets. Development and evaluation of imaging systems including instrumentation, image reconstruction algorithms, image analysis, and display. Development of molecular assay approaches leading to quantification of the biological information obtained in molecular imaging. Study of in vivo animal models of disease for the development of new molecular diagnostics and therapeutics. Extension of in vitro and in vivo discoveries using disease models, into well designed clinical research investigations. Clinical molecular imaging involving clinical investigations, clinical trials and medical management or cost-effectiveness studies.

Topics Covered (Recognized by AI)
Medicine94.4%Biology88.2%Genetics71.1%Internal medicine65.7%Radiology61.2%Chemistry58.4%Nuclear medicine56.1%Psychology52%Biochemistry49.3%Neuroscience47.6%Physics47.2%Biotechnology41.2%Positron emission tomography41%Pathology40%In vivo39.8%Surgery28.1%Computer science25.1%Cancer23.2%In vitro22.3%Immunology22.2%Endocrinology21%Optics20.3%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Q2
Rank93/217
IndexSCIE
JCISCIE2026

RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Q2
Rank86/217
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.5
Articles / Year65
Total Citations13
2025
IF2.5
Articles / Year105
Total Citations202
2024
IF3
Articles / Year82
Total Citations334
2023
IF3.1
Articles / Year91
Total Citations696
2022
IF3.484
Articles / Year102
Total Citations1,284

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,693Scopus Q2SCImago Profile
Scopus Coverage:2002-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.74

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.79

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,140 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations846
3-Year Documents309
Citable Documents299

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate38.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ2
Radiology, Nuclear Medicine and ImagingQ2
Cancer ResearchQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Molecular Imaging and Biology (acronym: mibi, abbr: MOL IMAGING BIOL, ISSN: 1536-1632) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer International Publishing in United States since 2005. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.740 (Q2), an H-index of 83.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 111 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,140 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer International Publishing
Publication Language
English
Frequency
Bimonthly
Founding Year
2005
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 05f603cc-c9f9-44dd-8d99-a20ea925d58f
Database Updated: 2026-10-01